The effects of low doses of Δ-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults

Neuropsychopharmacology

Volumn 32, Issue 2, 2007, Pages 417-428

  Rogers, Robert D ^a   Wakeley, Judi ^a   Robson, Phillip J ^a,b   Bhagwagar, Zubin ^a   Makela, Petra ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Porton Down Science Park   (United Kingdom)

Author keywords

9 tetrahydrocannabinol; Cannabis; CB1 receptors; Decision making; Punishment; Reward

Indexed keywords

DRONABINOL;

ADULT; ARTICLE; ATTENTION; AVERSION; CONTROLLED STUDY; DECISION MAKING; DOSE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REINFORCEMENT;

ADULT; AGE FACTORS; ATTENTION; BRAIN; CATECHOLAMINES; COGNITION; COGNITION DISORDERS; CROSS-OVER STUDIES; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHOTROPIC DRUGS; REACTION TIME; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT (PSYCHOLOGY); RISK-TAKING; TETRAHYDROCANNABINOL;

EID: 33846246339     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301175     Document Type: Article

References (63)

1. Ameri A (1999). The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348.
2. Baron J (2000). Thinking and Deciding, 3rd edn. Cambridge University Press: UK.
3. Bechara A, Damasio H (2002). Decision-making and addiction (part 1): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 40: 1675-1689.
4. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001). Decision-making deficits linked to dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389.
5. Bechara A, Tranel D, Damasio H, Damasio AR (1996). Failure to respond automatically to anticipated future outcomes following damage to prefrontal cortex. Cerebral Cortex 6: 215-225.
6. Bond A, Lader M (1974). The use of anologue scales in rating subjective feelings. Br J Med Psychol 47: 211-218.
7. Brady KT, Balster RL (1980). The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed interval performance in rhesus monkeys. Psychopharmacology 72: 21-26.
8. Curran HV, Brignell C, Fletcher S, Middleton P, Henry J (2002). Cognitive and subjective dose-response effects of acute doses of oral Δ-9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 164: 61-70.
9. Damasio AR (1994). Descartes Error. Grossman/Pullman: New York.
10. Dayan P, Balleine BW (2002). Reward, motivation, and reinforcement learning. Neuron 36: 285-298.
11. Deakin JB, Aitken MR, Dowson JH, Robbins TW, Sahakian BJ (2004). Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology 173: 88-97.
12. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders. New York State Psychiatric Institute: New York.
13. Foltin RW, Fischman MW, Brady JV, Kelly TH, Bernstein DJ, Nellis MJ (1989). Motivational effects of smoked marijuana: behavioral contingencies and high probability recreational activities. Pharmacol Biochem Behav 34: 871-877.
14. Gardner EL, Lowinson JH (1991). Marijuana's interaction with brain reward systems: update 1991. Pharmacol Biochem Behav 40: 571-580.
15. Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D et al(1988). Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology 96: 142-144.
16. Gardner EL, Vorel SR (1998). Cannabinoid transmission and reward-related events. Neurobiol Dis 5: 502-533.
17. Gevins A, Smith ME, McEvoy LK (2002). Tracking and cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures. Neuropsychopharmacology 26: 27-39.
18. Goldstein WM, Hogarth RM (1997). Research on Judgment and Decision-Making. Currents, Connections and Controversies. Cambridge University Press: Cambridge, UK.
19. Guy GW, Robson PJ (2003). A Phase I, double-blind, three-way crossover study to assess the pharmacokinetic profile of cannabis based medicine extract (CBME) administered sublingually in variant cannabinoid ratios in normal healthy volunteers (GWPK0215). J Cannabis Therapeut 3: 121-152.
20. Haertzen CH, Hickey JE (1987). Addiction research center inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth MA (ed). Methods of Assessing the Reinforcing Properties of Abused Drugs. Springer-Verlag: New York. pp 489-524.
21. Haney M, Comer SD, Ward AS, Foltin RW, Fischman MW (1997). Factors influencing marijuana self-administration by humans. Behav Pharmacol 8: 101-112.
22. Hansteen RW, Miller RD, Lonero L, Reid LD, Jones B (1976). Effects of cannabis and alcohol on automobile driving and psychomotor tracking. Ann NY Acad Sci 282: 254-256.
23. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, deCosta BR et al(1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci 87: 1932-1936.
24. Howell DC (1987). Statistical Methods for Psychology, 2nd edn. Duxbury Press: Boston. p 11.
25. Iversen LL (2000). The Science of Marijuana. Oxford University Press: Oxford.
26. Janowsky DS, Meacham MP, Blaine JD, Schoor M, Bozzetti LP (1976). Marijuana effects on simulated flying ability. Am J Psychiatry 133: 384-388.
27. Kagel JH, Battalio RC, Milus CG (1980). Marijuna and work performance: results from an experiment. J Human Reform 15: 373-395.
28. Kahneman D, Tversky A (1979). Prospect theory: an analysis of decision-making. Econometrica 47: 263-291.
29. Kahneman D, Tversky A (2000). Choices, Values and Frames. Cambridge University Press: Cambridge.
30. 9-tetrahydrocannabinol on repeated acquisition and performance of response sequences and on self-report in humans. Behav Pharmacol 5: 71-78.
31. Kelly TH, Foltin RW, Fischman MW (1993). Effects of smoked marijuana on heart rate, drug ratings, and task performance by humans. Behav Pharmacol 4: 167-178.
32. Kirk JM, de Wit H (1999). Responses to oral Δ9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 63: 137-142.
33. Kirk JM, Doty P, de Wit H (1998). Effects of expectancies on subjective responses to oral Δ9-tetrahydrocannabinol. Pharmacol Biochem Behav 59: 287-293.
34. Lane SD, Cherek DR (2002). Marijuana effects on sensitivity to reinforcement in humans. Neuropsychopharmacology 26: 520-529.
35. Lane SD, Cherek DR, Tcheremissine OV, Lieving LM, Pietras CJ (2005b). Acute effects of marijuana effects on human risk taking. Neuropsychopharmacology 30: 800-809.
36. Lane SD, Tcheremissine OV, Lieving LM, Nouvion SO, Cherek DR (2005a). Acute effects of alprazolam on risky decision making in humans. Psychopharmacology 181: 364-373.
37. Liguori A, Gatto CP, Robinson JH (1998). Effects of marijuana on equilibrium, psychomotor performance, and simulated driving. Behav Pharmacol 9: 599-609.
38. Luciana M, Depue RA, Arbisi P, Leon A (1992). Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cognitive Neurosci 4: 58-68.
39. Makela P, Wakeley J, Gijsman H, Robson PJ, Bhagwagar Z, Rogers RD (2006). Low doses of D-9 tetrahydrocannabinol (THC) have divergent effects on short-term spatial memory in young, healthy adults. Neurosychopharmacology 31: 462-470.
40. Mathew RJ, Wilson WH, Turkington TG, Hawk TC, Coleman RE, DeGrado TR et al(2002). Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. Psychiatr Res 116: 173-185.
41. Mehta MA, Goodyer IM, Sahakian BJ (2004). Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatr 45: 293-305.
42. Miles CG, Congreve GR, Gibbins RJ, Marshman J, Devenyi P, Hicks RC (1974). An experimental study of the effects of daily cannabis smoking on behaviour patterns. Acta Pharmacol Toxicol 34(Suppl 1): 1-44.
43. Miller LL, McFarland DJ, Cornett TL, Brightwell DR, Wilker A (1977). Marijuana: effects on free recall and subjective organization of pictures and words. Psychopharmacology 55: 257-262.
44. Morgan MJ, Impallomeni LC, Pirona A, Rogers RD (2006). Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naïve controls. Neuropsychopharmacology 31: 1562-1573.
45. Nelson HE (1982). National Adult Reading Test Manual. NFER-Nelson: Windsor, Berks.
46. O'Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC (2002). Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 26: 802-816.
47. Pihl RO, Sigal H (1978). Motivation levels and the marihuana high. J Abnormal Psychol 87: 210-222.
48. Rahman S, Sahakian BJ, Cardinal RN, Rogers RD, Robbins TW (2001). Decision-making cognition in neuropsychiatric disorders. Decision making and neuropsychiatry. Trends Cognitive Sci 5: 271-277.
49. Ramaekers JG, Berghaus G, van-Laar M, Drummer OH (2004). Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Dependence 73: 109-119.
50. Ramaekers JG, Robbe HW, O'Hanlon JF (2000). Dose-related risk of motor vehicle crashes after cannabis use. Drug Alcohol Dependence 73: 109-119.
51. Robbe HWJ (1994). Influence of Marijuana on Driving. Institute of Human Psychopharmacology. University of Limburg: Maastricht.
52. Rogers RD, Everitt BJ, Baldacchino A, Blackmore AJ, Swainson R, London M et al(1999a). Dissociating deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20: 322-329.
53. Rogers RD, Lancaster M, Wakeley J, Bhagwagar Z (2004). The effects of beta-adrenoceptor blockade on components of human decision-making. Psychopharmacology 172: 157-164.
54. Rogers RD, Owen AM, Middleton HC, Pickard J, Robbins TW (1999b). Decision-making in humans activates multiple sites within orbital prefrontal cortex: a PET study. J Neurosc 20: 9029-9038.
55. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, Carter CS (2003). Typtophan depletion alters the decisionmaking of healthy volunteers through altered processing of reward cues. Neuropsycholpharmacology 1: 1-10.
56. Scarna A, McTavish SFB, Cowen PJ, Goodwin GM, Rogers RD (2005). The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making. Psychopharmacology 179: 761-768.
57. Schneider SL, Lopes LL (1986). Reflection in preference under risk: who and when may suggest why. J Exp Psychol: Human Percept Performance 12: 535-548.
58. Schulze GE, McMillan DE, Bailey JR, Scallet AC, Ali SF, Slikker WJ et al(1989). Acute effects of marijuana smoke on complex operant behaviour in rhesus monkeys. Life Sci 45: 465-475.
59. Tanda G, Goldberg SR (2003). Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacologia 169: 115-134.
60. Tanda G, Pontieri FE, DiChiara G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276: 2048-2050.
61. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Valentine A (1996). Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res 67: 28-29.
62. von Winterfeldt D, Edwards W (1986). Decision Analysis and Behavioral Research. CUP: Cambridge.
63. Whitlow CT, Liguori A, Brooke Livengood L, Hart SL, Mussat-Whitlow BJ, Lambborn CM et al(2004). Long-term heavy marijuana use make costly decisions on a gambling task. Drug Alcohol Dependence 76: 107-111.